Concepedia

Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma

Kaoru Hatano, Jiro Kikuchi, Masaaki Takatoku, R Shimizu, Taeko Wada, M Ueda, Masaharu Nobuyoshi, Iekuni Oh, Kazuya Sato, Toshiyuki Suzuki,

Oncogene · 2008 · 190 citations · 35 references

DOI

Concepts

References

35

A new mathematical model for relative quantification in real-time RT-PCR

Michael W. Pfaffl · Nucleic Acids Research · 2001 · 34.9K citations · Full text

, , +12

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Paul G. Richardson, Bart Barlogie, James R. Berenson et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text

, , +10

Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma

Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster et al. · New England Journal of Medicine · 2005 · 2.5K citations · Full text

, , +14

Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

Robert A. Kyle, Morie A. Gertz, Thomas E. Witzig et al. · Mayo Clinic Proceedings · 2003 · 2.4K citations

, , +10

The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

Teru Hideshima, Paul G. Richardson, D Chauhan et al. · PubMed · 2001 · 1.5K citations

, , +17